Antimalarial activity of 3-hydroxyalkyl-2-methylene-propionic acid derivatives. 1999

M K Kundu, and M K Kundu, and N Sundar, and S K Kumar, and S V Bhat, and S Biswas, and N Valecha
Department of Chemistry, Indian Institute of Technology, Powai, Bombay.

Several Baylis-Hillman adducts and their derivatives were synthesized and evaluated as targeted potential anti-malarials. The compounds 4, 7 and 9 were found to have highest potency against P. falciparum in vitro. The in vivo test result of compound 4 and 9 against P. berghei demonstrated activity at 80 mg/Kg dose level.

UI MeSH Term Description Entries
D010962 Plasmodium berghei A protozoan parasite of rodents transmitted by the mosquito Anopheles dureni. Plasmodium bergheus,berghei, Plasmodium
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011422 Propionates Derivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure. Propanoate,Propanoic Acid,Propionate,Propanoates,Propanoic Acid Derivatives,Propanoic Acids,Propionic Acid Derivatives,Propionic Acids,Acid, Propanoic,Acids, Propanoic,Acids, Propionic,Derivatives, Propanoic Acid,Derivatives, Propionic Acid
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial

Related Publications

M K Kundu, and M K Kundu, and N Sundar, and S K Kumar, and S V Bhat, and S Biswas, and N Valecha
March 1983, Il Farmaco; edizione scientifica,
M K Kundu, and M K Kundu, and N Sundar, and S K Kumar, and S V Bhat, and S Biswas, and N Valecha
December 2011, Acta pharmaceutica (Zagreb, Croatia),
M K Kundu, and M K Kundu, and N Sundar, and S K Kumar, and S V Bhat, and S Biswas, and N Valecha
January 2005, Arzneimittel-Forschung,
M K Kundu, and M K Kundu, and N Sundar, and S K Kumar, and S V Bhat, and S Biswas, and N Valecha
April 1989, Die Pharmazie,
M K Kundu, and M K Kundu, and N Sundar, and S K Kumar, and S V Bhat, and S Biswas, and N Valecha
August 1976, Lancet (London, England),
M K Kundu, and M K Kundu, and N Sundar, and S K Kumar, and S V Bhat, and S Biswas, and N Valecha
May 1972, Die Pharmazie,
M K Kundu, and M K Kundu, and N Sundar, and S K Kumar, and S V Bhat, and S Biswas, and N Valecha
April 1972, Die Pharmazie,
M K Kundu, and M K Kundu, and N Sundar, and S K Kumar, and S V Bhat, and S Biswas, and N Valecha
December 1961, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
M K Kundu, and M K Kundu, and N Sundar, and S K Kumar, and S V Bhat, and S Biswas, and N Valecha
November 1991, Die Pharmazie,
M K Kundu, and M K Kundu, and N Sundar, and S K Kumar, and S V Bhat, and S Biswas, and N Valecha
February 2011, Beilstein journal of organic chemistry,
Copied contents to your clipboard!